CCM made reseller of Biocon’s human insulin medication

PETALING JAYA: Pharmaceutical firm CCM Duopharma Biotech Bhd has been appointed the reseller of human insulin medication by Biocon Sdn Bhd, the local subsidiary of Biocon Ltd, a biopharmaceutical company based in Bengaluru, India.

Biocon was awarded the contract to manufacture the insulin medication under the Health Ministry’s off-take programme. The contract, commencing Dec 2 last year, will last till Dec 1, 2019 with a total contract value of RM300mil.